Literature DB >> 18770859

Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome.

Elizabeth Goldmuntz1, Deborah A Driscoll, Beverly S Emanuel, Donna McDonald-McGinn, Minghua Mei, Elaine Zackai, Laura E Mitchell.   

Abstract

BACKGROUND: The phenotype associated with deletion of the 22q11.2 chromosomal region is highly variable, yet little is known about the source of this variability. Cardiovascular anomalies, including tetralogy of Fallot, truncus arteriosus, interrupted aortic arch type B, perimembranous ventricular septal defects, and aortic arch anomalies, occur in approximately 75% of individuals with a 22q11.2 deletion.
METHODS: Data from 343 subjects enrolled in a study of the 22q11.2 deletion syndrome were used to evaluate potential modifiers of the cardiac phenotype in this disorder. Subjects with and without cardiac malformations, and subjects with and without aortic arch anomalies were compared with respect to sex and race. In addition, in the subset of subjects from whom a DNA sample was available, genotypes for variants of four genes that are involved in the folate-homocysteine metabolic pathway and that have been implicated as risk factors for other birth defects were compared. Five variants in four genes were genotyped by heteroduplex or restriction digest assays. The chi-square or Fisher's exact test was used to evaluate the association between the cardiac phenotype and each potential modifier.
RESULTS: The cardiac phenotype observed in individuals with a 22q11.2 deletion was not significantly associated with either sex or race. The genetic variants that were evaluated also did not appear to be associated with the cardiovascular phenotype.
CONCLUSIONS: Variation in the cardiac phenotype observed between individuals with a 22q11.2 deletion does not appear to be related to sex, race, or five sequence variants in four folate-related genes that are located outside of the 22q11.2 region. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 18770859      PMCID: PMC2810963          DOI: 10.1002/bdra.20501

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  31 in total

1.  Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations.

Authors:  K D Wenstrom; G L Johanning; K E Johnston; M DuBard
Journal:  Am J Obstet Gynecol       Date:  2001-04       Impact factor: 8.661

2.  Infant methylenetetrahydrofolate reductase 677TT genotype is a risk factor for congenital heart disease.

Authors:  R Junker; S Kotthoff; H Vielhaber; S Halimeh; A Kosch; H G Koch; R Kassenböhmer; B Heineking; U Nowak-Göttl
Journal:  Cardiovasc Res       Date:  2001-08-01       Impact factor: 10.787

3.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

4.  Occurrence of congenital heart defects in relation to maternal mulitivitamin use.

Authors:  L D Botto; J Mulinare; J D Erickson
Journal:  Am J Epidemiol       Date:  2000-05-01       Impact factor: 4.897

5.  Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome.

Authors:  P J Scambler; A H Carey; R K Wyse; S Roach; J P Dumanski; M Nordenskjold; R Williamson
Journal:  Genomics       Date:  1991-05       Impact factor: 5.736

6.  Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion.

Authors:  Sulagna C Saitta; Stacy E Harris; Ann P Gaeth; Deborah A Driscoll; Donna M McDonald-McGinn; Melissa K Maisenbacher; Jill M Yersak; Prabir K Chakraborty; April M Hacker; Elaine H Zackai; Terry Ashley; Beverly S Emanuel
Journal:  Hum Mol Genet       Date:  2003-12-17       Impact factor: 6.150

7.  A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population.

Authors:  Lorenzo D Botto; Kristin May; Paul M Fernhoff; Adolfo Correa; Karlene Coleman; Sonja A Rasmussen; Robert K Merritt; Leslie A O'Leary; Lee-Yang Wong; E Marsha Elixson; William T Mahle; Robert M Campbell
Journal:  Pediatrics       Date:  2003-07       Impact factor: 7.124

8.  VEGF: a modifier of the del22q11 (DiGeorge) syndrome?

Authors:  Ingeborg Stalmans; Diether Lambrechts; Frederik De Smet; Sandra Jansen; Jian Wang; Sunit Maity; Paige Kneer; Maren von der Ohe; Ann Swillen; Christa Maes; Marc Gewillig; Daniel G M Molin; Peter Hellings; Thurid Boetel; Maartin Haardt; Veerle Compernolle; Mieke Dewerchin; Stephane Plaisance; Robert Vlietinck; Beverly Emanuel; Adriana C Gittenberger-de Groot; Peter Scambler; Bernice Morrow; Deborah A Driscol; Lieve Moons; Camila V Esguerra; Geert Carmeliet; Annett Behn-Krappa; Koen Devriendt; Désiré Collen; Simon J Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

9.  Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.

Authors:  A E Czeizel; I Dudás
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

Review 10.  Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics.

Authors:  Kathy J Jenkins; Adolfo Correa; Jeffrey A Feinstein; Lorenzo Botto; Amy E Britt; Stephen R Daniels; Marsha Elixson; Carole A Warnes; Catherine L Webb
Journal:  Circulation       Date:  2007-05-22       Impact factor: 29.690

View more
  10 in total

1.  Embryonic aortic arch hemodynamics are a functional biomarker for ethanol-induced congenital heart defects [Invited].

Authors:  Lindsy M Peterson; Shi Gu; Ganga Karunamuni; Michael W Jenkins; Michiko Watanabe; Andrew M Rollins
Journal:  Biomed Opt Express       Date:  2017-02-24       Impact factor: 3.732

2.  Copy-Number Variation of the Glucose Transporter Gene SLC2A3 and Congenital Heart Defects in the 22q11.2 Deletion Syndrome.

Authors:  Elisabeth E Mlynarski; Molly B Sheridan; Michael Xie; Tingwei Guo; Silvia E Racedo; Donna M McDonald-McGinn; Xiaowu Gai; Eva W C Chow; Jacob Vorstman; Ann Swillen; Koen Devriendt; Jeroen Breckpot; Maria Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Nicole Philip; Tony J Simon; Amy E Roberts; Małgorzata Piotrowicz; Carrie E Bearden; Stephan Eliez; Doron Gothelf; Karlene Coleman; Wendy R Kates; Marcella Devoto; Elaine Zackai; Damian Heine-Suñer; Tamim H Shaikh; Anne S Bassett; Elizabeth Goldmuntz; Bernice E Morrow; Beverly S Emanuel
Journal:  Am J Hum Genet       Date:  2015-04-16       Impact factor: 11.025

Review 3.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

Review 4.  Transgenerational cardiology: One way to a baby's heart is through the mother.

Authors:  Patrick Y Jay; Ehiole Akhirome; Rachel A Magnan; M Rebecca Zhang; Lillian Kang; Yidan Qin; Nelson Ugwu; Suk Dev Regmi; Julie M Nogee; James M Cheverud
Journal:  Mol Cell Endocrinol       Date:  2016-08-20       Impact factor: 4.102

5.  Genetic counseling in the adult with congenital heart disease: what is the role?

Authors:  Luke Burchill; Steven Greenway; Candice K Silversides; Seema Mital
Journal:  Curr Cardiol Rep       Date:  2011-08       Impact factor: 2.931

6.  Multiplexed quantitative real-time PCR to detect 22q11.2 deletion in patients with congenital heart disease.

Authors:  Aoy Tomita-Mitchell; Donna K Mahnke; Joshua M Larson; Sujana Ghanta; Ying Feng; Pippa M Simpson; Ulrich Broeckel; Kelly Duffy; James S Tweddell; William J Grossman; John M Routes; Michael E Mitchell
Journal:  Physiol Genomics       Date:  2010-06-15       Impact factor: 3.107

7.  Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome.

Authors:  Elisabeth E Mlynarski; Michael Xie; Deanne Taylor; Molly B Sheridan; Tingwei Guo; Silvia E Racedo; Donna M McDonald-McGinn; Eva W C Chow; Jacob Vorstman; Ann Swillen; Koen Devriendt; Jeroen Breckpot; Maria Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Nicole Philip; Tony J Simon; Amy E Roberts; Małgorzata Piotrowicz; Carrie E Bearden; Stephan Eliez; Doron Gothelf; Karlene Coleman; Wendy R Kates; Marcella Devoto; Elaine Zackai; Damian Heine-Suñer; Elizabeth Goldmuntz; Anne S Bassett; Bernice E Morrow; Beverly S Emanuel
Journal:  Hum Genet       Date:  2016-01-07       Impact factor: 4.132

8.  Biallelic expression of Tbx1 protects the embryo from developmental defects caused by increased receptor tyrosine kinase signaling.

Authors:  Subreena Simrick; Dorota Szumska; Jennifer R Gardiner; Kieran Jones; Karun Sagar; Bernice Morrow; Shoumo Bhattacharya; M Albert Basson
Journal:  Dev Dyn       Date:  2012-06-26       Impact factor: 3.780

9.  Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects.

Authors:  Emilia Cirillo; Giuliana Giardino; Vera Gallo; Pamela Puliafito; Chiara Azzari; Rosa Bacchetta; Fabio Cardinale; Maria Pia Cicalese; Rita Consolini; Silvana Martino; Baldassarre Martire; Cristina Molinatto; Alessandro Plebani; Gioacchino Scarano; Annarosa Soresina; Caterina Cancrini; Paolo Rossi; Maria Cristina Digilio; Claudio Pignata
Journal:  BMC Med Genet       Date:  2014-01-02       Impact factor: 2.103

10.  Genetic abnormalities/syndromes significantly impact perioperative outcomes of conotruncal heart defects.

Authors:  Subhrajit Lahiri; Wernovsky Gil; Salyakina Daria; Gruber Joshua; Jayakar Parul; Burke Redmond; Welch Elizabeth
Journal:  Ann Pediatr Cardiol       Date:  2019-10-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.